Illinois [US], September 24 (ANI): Researchers from Northwestern Medicine discovered a new drug that was highly effective in lowering the signs and symptoms of moderate-to-severe eczema. This is the first trial to use a biologic therapy (monoclonal antibody) instead of immune-suppressing dru
Illinois [US], September 19 (ANI): Researchers involved in a new multi-site international phase III study led by Northwestern Medicine found that a new drug was highly effective in reducing the signs and symptoms of moderate-to-severe eczema. This is the first study to treat moderate-to-seve